John Kao Sells 180,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 180,000 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $21.11, for a total transaction of $3,799,800.00. Following the completion of the transaction, the chief executive officer owned 2,832,641 shares in the company, valued at $59,797,051.51. This trade represents a 5.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Alignment Healthcare Trading Up 3.4%

NASDAQ:ALHC opened at $22.50 on Friday. Alignment Healthcare, Inc. has a one year low of $11.63 and a one year high of $23.03. The business has a fifty day moving average price of $19.08 and a 200-day moving average price of $16.76. The firm has a market capitalization of $4.50 billion, a price-to-earnings ratio of -187.50, a price-to-earnings-growth ratio of 5.73 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. The business had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.During the same quarter in the previous year, the company posted ($0.14) earnings per share. Alignment Healthcare’s revenue for the quarter was up 43.5% on a year-over-year basis. Sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Larson Financial Group LLC purchased a new stake in Alignment Healthcare during the third quarter valued at $33,000. SBI Securities Co. Ltd. raised its position in shares of Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after buying an additional 2,970 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after acquiring an additional 987 shares during the last quarter. KBC Group NV bought a new stake in Alignment Healthcare during the second quarter worth approximately $44,000. Finally, Signaturefd LLC increased its stake in Alignment Healthcare by 142.6% during the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ALHC has been the subject of several recent analyst reports. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. The Goldman Sachs Group reiterated a “buy” rating and set a $22.00 target price on shares of Alignment Healthcare in a research report on Monday, November 3rd. Piper Sandler lifted their target price on Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, January 6th. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Finally, UBS Group increased their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $21.55.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.